Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Transcriptomics Market?

Over the past few years, the transcriptomics market has experienced significant growth. The market size, which was at $6.51 billion in 2024, is anticipated to expand to $7.04 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.2%. The historic growth is credited to a heightened focus on personalized medicine, an increase in cancer incidence, the application of genomics in clinical diagnostics, the progress of ribonucleic acid sequencing, and the escalating demand for biomarker discovery.

In the coming years, the transcriptomics market is projected to witness considerable expansion, shooting up to $9.57 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The expected surge during the forecast period can be attributed to the growing popularity of single-cell ribonucleic acid sequencing, the increasing use of spatial transcriptomics, the escalating demand for multiomics approaches, the heightened emphasis on early disease detection, and growing awareness about the significance of non-coding ribonucleic acids. The forecast period will also see key trends like advancements in next-generation sequencing (NGS) technologies, progressions in spatial transcriptomics technology, development in bioinformatics tools, incorporation of machine learning into transcriptomics, and technological progressions in real-time transcriptomic analysis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Transcriptomics Market?

The emergence of personalized medicine is projected to fuel growth in the transcriptomics market. This medical practice, which tailors treatments to an individual’s genetic makeup, lifestyle, and environment, is gaining traction due to improvements in genetic sequencing. This allows for treatments designed to cater to unique genetic profiles, enhancing their efficacy. Transcriptomics reveals individual gene expression patterns and shapes treatments according to each patient’s specific biology. This leads to improved therapeutic effectiveness, fewer side effects, and the ability to detect diseases early. In support of this, the Personalized Medicine Coalition, a healthcare organization from the US, reported in February 2024 that the FDA had given the green light to 16 fresh treatments for patients with rare diseases in 2023, a significant increase from just six in 2022. Consequently, the growing uptake of personalized medicine is a key driver for the transcriptomics market.

What Are The Key Segment Trends Observed In The Transcriptomics Market?

The transcriptomicsmarket covered in this report is segmented –

1) By Type: Instruments; Consumables; Software; Services

2) By Technology: Micro Array; Real-Time Quantitative Polymerase Chain Reaction; Sequencing Technologies

3) By Application: Diagnostics And Disease Profiling; Drug Discovery; Other Applications

4) By End-User: Academic And Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Microarray Instruments; Sequencing Instruments; Polymerase Chain Reaction (PCR) Instruments; Other Transcriptomics Instruments

2) By Consumables: Reagents; Probes; Kits; Chips

3) By Software: Data Analysis Software: Data Management Software; Visualization Software: Bioinformatics Software

4) By Services: Data Analysis Services; Sample Preparation Services; Sequencing Services; Consulting Services

What Strategic Shifts And Innovations Are Influencing The Transcriptomics Market?

Major firms in the transcriptomics industry are concentrating their efforts on creating cutting-edge items like single-cell spatial panels that can provide a deeper understanding of cellular functions and the mechanics of diseases. Single-cell spatial panels combine single-cell transcriptomics with spatial data, shedding light on both cellular activity and tissue architecture. This is achieved by scrutinizing gene expression on the level of individual cells while also maintaining each cell’s location within the tissue. For instance, NanoString Technologies, an American biotech firm, unleashed the CosMx 6,000 plex RNA Assay, a spatial molecular imaging assay, onto the market in February 2024. Notably, it marked the first commercial availability of a single-cell spatial panel capable of assessing over 6,000 RNA targets spanning nearly all human biological pathways. This innovative product, designed to be used with the CosMx Spatial Molecular Imager (SMI), allows researchers to profile genes at a single-cell and subcellular level with high precision and enhanced cell segmentation.

Who Are The Leading Companies Driving The Transcriptomics Market?

Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Which Region Is Forecasted To Lead The Transcriptomics Market In The Coming Years?

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

Browse Through More Reports Similar to the Global Transcriptomics Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense Rnai Therapeutics Market 2025

https://www.thebusinessresearchcompany.com/report/antisense-rnai-therapeutics-market

Dna Or Rna Sample Extraction And Isolation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-or-rna-sample-extraction-and-isolation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model